Evidence map›Paper›PMID 32031337›Full record

ArticleEMBO molecular medicine2020

MicroRNA exporter HuR clears the internalized pathogens by promoting pro-inflammatory response in infected macrophages.

Avijit Goswami, Kamalika Mukherjee, Anup Mazumder, Satarupa Ganguly, Ishita Mukherjee, Saikat Chakrabarti, Syamal Roy, Shyam Sundar, Krishnananda Chattopadhyay, Suvendra N Bhattacharyya

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Extracellular vesicles derived fromFrontiers in immunology · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Avijit Goswami *RNA Biology Research Laboratory, Molecular Genetics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Kamalika Mukherjee *RNA Biology Research Laboratory, Molecular Genetics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Anup Mazumder *RNA Biology Research Laboratory, Molecular Genetics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Satarupa Ganguly *RNA Biology Research Laboratory, Molecular Genetics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Ishita MukherjeeStructural Biology and Bio-informatics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.ORCID 0000-0003-0361-537X
Saikat ChakrabartiStructural Biology and Bio-informatics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.ORCID 0000-0002-8644-6016
Syamal RoyNational Institute of Pharmaceutical Educations and Research, Kolkata, India.
Shyam SundarDepartment of Medicine, Banaras Hindu University, Varanasi, India.
Krishnananda ChattopadhyayStructural Biology and Bio-informatics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.ORCID 0000-0002-1449-8909
Suvendra N BhattacharyyaRNA Biology Research Laboratory, Molecular Genetics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.ORCID 0000-0001-9697-3824
Indian Institute of Chemical Biology · INBanaras Hindu University · INNational Institute of Pharmaceutical Education and Research · IN

Funding

Department of Biotechnology, Ministry of Science and Technology (DBT) BT/IN/Swiss/53/SNB/2018-19DST | Science and Engineering Research Board (SERB) DST/SJF/LSA-03/2014-15DST | Science and Engineering Research Board (SERB) HRR/2016/000093DST | Science and Engineering Research Board (SERB) SB/S2/JCB-65/2014
6 · The paper itself

Abstract

HuR is a miRNA derepressor protein that can act as miRNA sponge for specific miRNAs to negate their action on target mRNAs. Here we have identified how HuR, by inducing extracellular vesicles-mediated export of miRNAs, ensures robust derepression of miRNA-repressed cytokines essential for strong pro-inflammatory response in activated mammalian macrophages. Leishmania donovani, the causative agent of visceral leishmaniasis, on the contrary alters immune response of the host macrophage by a variety of complex mechanisms to promote anti-inflammatory response essential for the survival of the parasite. We have found that during Leishmania infection, the pathogen targets HuR to promote onset of anti-inflammatory response in mammalian macrophages. In infected macrophages, Leishmania also upregulate protein phosphatase 2A that acts on Ago2 protein to keep it in dephosphorylated and miRNA-associated form. This causes robust repression of the miRNA-targeted pro-inflammatory cytokines to establish an anti-inflammatory response in infected macrophages. HuR has an inhibitory effect on protein phosphatase 2A expression, and mathematical modelling of macrophage activation process supports antagonistic miRNA-modulatory roles of HuR and protein phosphatase 2A which mutually balances immune response in macrophage by targeting miRNA function. Supporting this model, ectopic expression of the protein HuR and simultaneous inhibition of protein phosphatase 2A induce strong pro-inflammatory response in the host macrophage to prevent the virulent antimonial drug-sensitive or drug-resistant form of L. donovani infection. Thus, HuR can act as a balancing factor of immune responses to curtail the macrophage infection process by the protozoan parasite.

Indexed as

Leishmania donovaniMacrophage ActivationMicroRNAsAnimalsELAV-Like Protein 1Leishmaniasis, VisceralMacrophagesELAV-Like Protein 1MicroRNAsAgo2 dephosphorylationdrug-resistant Leishmaniahost-parasite interactionmiRNA exportprotein phosphatase 2A

Identifiers

PMID32031337
PMCPMC7059013
OpenAlexW3005086862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.